financetom
Business
financetom
/
Business
/
Reports of dollar's demise are greatly exaggerated, JPMorgan says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Reports of dollar's demise are greatly exaggerated, JPMorgan says
Sep 6, 2024 12:22 PM

LONDON (Reuters) - Suggestions that the dollar's dominance of the global financial system is ending are wide of the mark, JPMorgan said on Wednesday, despite some dramatic signs of change in commodity markets and certain trading blocs.

China's rise and the use of economic sanctions on the likes of Russia mean there is a trend of diversification away from the dollar, JPMorgan said, but reasons for the U.S. currency's dominance remain "well-entrenched and structural in nature".

It pointed to the rising amounts of dollar-denominated bank deposits in emerging markets, sovereign wealth fund behaviour and non-reserve foreign assets, saying it "more than offset" the dollar's secular decline in overall emerging market FX reserve holdings.

The dollar's share in total world liabilities is still on the rise too thanks to record amounts of debt issuance and even talk of de-dollarization in China appeared "exaggerated" despite geopolitical rivalry.

"Meaningful erosion of dollar dominance is likely to take decades, and the decline in the dollar's share of global trade and overall FX reserve holdings should not be confused with de-dollarization," the investment bank's report said.

Areas where significant changes are happening include commodities markets where oil trading is increasingly done in non-USD currencies and demand from central banks and emerging market consumers for gold has boomed.

The most "underappreciated risk to USD hegemony" was a possible fragmentation of the international payments system where the dollar has long been all powerful, the bank argued.

China and India are the global leaders in terms of e-commerce innovation and activity whereas the U.S. and Western Europe's share is now less than 30%.

Washington's use of tough financial sanctions means Russia, China and other countries are building alternatives to the SWIFT bank-to-bank system.

Dozens of central banks are piloting new digital versions of their national currencies that could also make avoiding the U.S. banking system easier.

"The genuine confidence of the private sector in the dollar as a store of value seems uncontested," JPMorgan's report said.

"However, we are witnessing greater diversification and important shifts in cross-border transactions as a result of sanctions against Russia, China's efforts to bolster usage of the renminbi, and geoeconomic fragmentation."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rambus Insider Sold Shares Worth $255,026, According to a Recent SEC Filing
Rambus Insider Sold Shares Worth $255,026, According to a Recent SEC Filing
Mar 8, 2024
01:50 PM EST, 03/08/2024 (MT Newswires) -- John Shinn, Senior Vice President, General Counsel, on March 07, 2024, sold 3,928 shares in Rambus ( RMBS ) for $255,026. Following the Form 4 filing with the SEC, Shinn has control over a total of 28,448 shares of the company, with 28,448 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/917273/000091727324000036/xslF345X03/wk-form4_1709922983.xml Price: 64.04, Change: -1.36,...
BMO on Sleep Country's Q4
BMO on Sleep Country's Q4
Mar 8, 2024
01:56 PM EST, 03/08/2024 (MT Newswires) -- Sleep Country reported a Q4/23 earnings beat. However, macro weighed on SSSG (-3.2%, above -7.5% forecast). BMO notes that the macro backdrop to remain unpredictable through 2024E. In the meantime, Sleep Country is well-positioned to weather the weakness and achieve market share gains for everything sleep, while continuing to invest in its sleep...
FDA approves Novo Nordisk's Wegovy for use in reducing heart attack risks
FDA approves Novo Nordisk's Wegovy for use in reducing heart attack risks
Mar 8, 2024
March 8 (Reuters) - The U.S. FDA has approved Novo Nordisk's Wegovy for use in lowering the risk of stroke and heart attack in overweight or obese adults, the Danish drugmaker said on Friday. ...
Why BigBear.ai Stock Is Dropping After Earnings
Why BigBear.ai Stock Is Dropping After Earnings
Mar 8, 2024
BigBear.ai ( BBAI ), Inc. shares are dropping Friday after the company posted worse-than-expected fourth-quarter financial results Thursday after the bell. The Details: BigBear.ai ( BBAI ) reported quarterly losses of 14 cents per share, which missed the consensus estimate of losses of 5 cents per share. Quarterly sales came in at $40.563 million, missing the analyst consensus estimate of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved